GlassScriptPhysician profile
Constantine G Scordalakes
NPI 1437235645
$22,363.81
in general payments reported to CMS, 2019-2025
51 companies · $2,240 in 2025
The $2,240 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,009 · 2020: $2,551 · 2021: $2,135 · 2022: $4,529 · 2023: $2,836 · 2024: $1,064 · 2025: $2,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,071 · Travel and Lodging: $1,958 · Education: $85.95 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,071.46 |
| Travel and Lodging | $1,958.49 |
| Education | $85.95 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $5,417.52 | 2019-2021 | |
| Axonics, INC. | $3,235.55 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $1,993.70 | 2019 | |
| Intuitive Surgical, INC. | $1,589.95 | 2023 | Da Vinci Surgical System |
| Medtronic, INC. | $1,441.17 | 2021-2025 | Altaviva, Ligasure |
| Agile Therapeutics, INC. | $1,233.30 | 2021-2022 | |
| Abbvie INC. | $1,151.73 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Coloplast Corp | $846.76 | 2019-2022 | |
| Astellas Pharma US INC | $827.74 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $445.57 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $354.78 | 2021-2025 | |
| Biogen, INC. | $344.83 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $318.50 | 2019-2024 | Enseal X1, Harmonic |
| Amgen INC. | $276.77 | 2019-2024 | Evenity, Prolia |
| Daiichi Sankyo INC. | $270.11 | 2020-2023 | Injectafer |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $229.13 | 2019-2024 | |
| Hologic Sales and Service, LLC | $197.48 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Novasure, Coolseal Generator |
| Boston Scientific Corporation | $188.02 | 2019-2024 | Advantage System, Solyx Sis System |
| Bayer Healthcare Pharmaceuticals INC. | $170.33 | 2019-2025 | |
| Novo Nordisk INC | $163.03 | 2019-2025 | Wegovy |
| Gynesonics, INC. | $146.52 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medical Device Business Services, INC. | $143.95 | 2019-2022 | |
| Myovant Sciences INC. | $135.78 | 2021-2022 | |
| Urovant Sciences INC | $118.15 | 2021-2022 | |
| Sage Therapeutics, LLC | $114.24 | 2022-2023 | |
| Aspira Women'S Health INC | $102.21 | 2023 | Ova1 |
| Avion Pharmaceuticals | $92.83 | 2020-2023 | Balcoltra |
| Therapeuticsmd, INC. | $92.16 | 2019-2022 | |
| Exeltis, USA INC. | $83.62 | 2023-2025 | Slynd |
| Organon LLC | $78.43 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $60.58 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $59.24 | 2019-2021 | |
| Radius Health, INC. | $57.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.05 | 2019-2020 | |
| Evofem Biosciences, INC. | $39.57 | 2021 | |
| Applied Medical Resources Corporation | $34.09 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.20 | 2021-2024 | Xifaxan |
| Vertical Pharmaceuticals, LLC | $25.58 | 2019 | |
| Laborie Medical Technologies Corp. | $22.48 | 2023 | |
| Allergan, INC. | $21.12 | 2019 | |
| Duchesnay USA Incorporated | $19.21 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.45 | 2021 | |
| Scynexis, INC. | $15.79 | 2021 | |
| Covidien LP | $14.62 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $14.25 | 2023 | Vivjoa |
| Exact Sciences Corporation | $14.12 | 2025 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $13.85 | 2021 | |
| Lilly USA, LLC | $13.16 | 2024 | Zepbound |
| Dysis Medical, INC. | $12.43 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Scordalakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.